Trial
NCT03547700
Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Michigan Rogel Cancer Center
Collaborators
Takeda; Big Ten Cancer Research Consortium
Condition
Lymphoma, T-Cell, Peripheral
Intervention
Romidepsin
Why stopped
Lack of accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-06